The subcutaneous implantable cardioverter-defibrillator is an effective alternative to transvenous systems for preventing sudden cardiac death, avoiding vascular and lead-related complications.
This review summarizes technical considerations and best practices for S-ICD implantation to optimize device function and minimize surgical and electrical complications.
An implantable cardioverter-defibrillator (ICD) was developed to provide protection against sudden cardiac death. Despite being effective in terminating ventricular arrhythmias, traditional transvenous ICDs appeared over time to have certain limitations related to the need for vascular access and the presence of foreign material inside the circulatory system (namely lead failure and infections). A subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to overcome those limitations and to provide prevention against sudden cardiac death from outside the cardiovascular system. Utilization of that modern method of treatment is constantly increasing worldwide, and new centers incorporate implantation of that system in their portfolio. This review aims to present the most relevant issues related to S-ICD implantation procedure, based on experience of the authors and an extensive literature search.
Budrejko et al. (Mon,) conducted a review in Sudden cardiac death. Subcutaneous implantable cardioverter-defibrillator (S-ICD) vs. Transvenous implantable cardioverter-defibrillator (TV-ICD) was evaluated. The subcutaneous implantable cardioverter-defibrillator is an effective alternative to transvenous systems for preventing sudden cardiac death, avoiding vascular and lead-related complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: